statistiche ricercatore

Continente	#
NA - Nord America	969
AS - Asia	350
EU - Europa	217
SA - Sud America	46
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	10
Totale	1.630

Nazione	#
US - Stati Uniti d'America	956
SG - Singapore	162
CN - Cina	67
VN - Vietnam	46
DE - Germania	41
BR - Brasile	32
IT - Italia	32
RU - Federazione Russa	32
HK - Hong Kong	31
GB - Regno Unito	23
FR - Francia	16
IN - India	16
UA - Ucraina	14
BE - Belgio	11
FI - Finlandia	11
CZ - Repubblica Ceca	8
CA - Canada	7
IE - Irlanda	7
ES - Italia	5
BD - Bangladesh	4
CO - Colombia	4
EC - Ecuador	4
JP - Giappone	4
PL - Polonia	4
ZA - Sudafrica	4
AR - Argentina	3
LT - Lituania	3
SE - Svezia	3
AT - Austria	2
IQ - Iraq	2
IR - Iran	2
MA - Marocco	2
MX - Messico	2
PK - Pakistan	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BO - Bolivia	1
CR - Costa Rica	1
EG - Egitto	1
EU - Europa	1
GE - Georgia	1
GP - Guadalupe	1
GR - Grecia	1
HN - Honduras	1
ID - Indonesia	1
KR - Corea	1
KZ - Kazakistan	1
LB - Libano	1
LV - Lettonia	1
MN - Mongolia	1
MZ - Mozambico	1
NL - Olanda	1
NP - Nepal	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TJ - Tagikistan	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.593

Nome	#
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker	200
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression	186
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma	170
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma	161
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients	160
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario	138
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis	137
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study	127
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study	96
Melanoma immunotherapy: strategies to overcome pharmacological resistance	91
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva	90
Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?	74
Totale	1.630

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	93	0	0	0	0	4	0	6	6	1	13	51	12
2022/2023	159	13	25	3	22	19	27	1	8	23	2	9	7
2023/2024	87	9	1	3	5	12	26	0	6	5	2	0	18
2024/2025	251	8	14	7	17	19	13	23	15	31	22	31	51
2025/2026	588	84	48	27	60	98	48	69	14	56	40	30	14
2026/2027	74	8	26	38	2	0	0	0	0	0	0	0	0
Totale													1.630